The term "C47E8.4 Antibody" does not appear in any of the 10 provided sources. This suggests either:
Nomenclature ambiguity: Potential confusion with similarly named antibodies (e.g., CD47, Cytokeratin 4, or AK4 antibodies).
Novel or proprietary designation: The antibody may be under development or described in non-public, specialized literature.
While "C47E8.4 Antibody" is not directly cited, several antibodies with similar naming conventions or functional roles are discussed:
To address gaps in information:
Verify nomenclature: Confirm the correct spelling and target antigen of "C47E8.4 Antibody."
Explore proprietary databases: Check specialized antibody catalogs (e.g., Bio-Techne, Cell Signaling Technology) for non-public entries.
Review preclinical studies: Search platforms like PubMed or ClinicalTrials.gov for unpublished or early-stage research.
While "C47E8.4 Antibody" remains undefined, the search results highlight critical antibody development principles:
Target specificity: Antibodies are engineered to bind unique epitopes (e.g., CD47’s SIRPα-binding domain ).
Isotype engineering: IgG4 variants reduce off-target effects (e.g., minimized ADCC in anti-CD47 therapies ).
Validation methods: Flow cytometry, Western blot, and IHC are standard for confirming antibody specificity .
The C47E8.4 antibody has been validated for several research applications, primarily:
These applications have been verified to ensure proper identification of the target antigen. While these represent the primary validated uses, researchers may explore additional applications such as immunohistochemistry or immunofluorescence, particularly using the polyacrylamide embedding technique for whole-mount C. elegans preparations .
For optimal preservation of antibody activity, the C47E8.4 antibody should be stored at -20°C or -80°C immediately upon receipt . Repeated freeze-thaw cycles should be strictly avoided as they can lead to protein denaturation and loss of binding activity. The antibody is supplied in a liquid form with a storage buffer containing 0.03% Proclin 300 as a preservative, 50% glycerol, and 0.01M PBS at pH 7.4 . This formulation helps maintain stability during storage. For working solutions, aliquoting the antibody into smaller volumes before freezing is recommended to minimize freeze-thaw cycles when conducting repeated experiments.
An optimized protocol for immunostaining C. elegans with antibodies like C47E8.4 involves a gel-based immobilization method combined with chemical and enzymatic permeabilization:
Harvest 200-500 worms in S-buffer or M9 buffer
Wash worms twice to remove residual bacteria
Fix worms in 60% isopropanol for at least 10 minutes
Wash three times with 0.5% PBS-T followed by PBS
Immobilize worms in polyacrylamide by incubating in monomer solution at 4°C for ≥1 hour
Mount on slides and proceed with permeabilization
Apply primary antibody (C47E8.4 antibody) at appropriate dilution
Wash and apply fluorescently-labeled secondary antibody
This protocol enables whole-body immunostaining while maintaining the structural integrity of the worm, unlike traditional methods such as freeze-cracking or dissection .
Fixation is a critical step that significantly impacts antibody binding to C47E8.4. Different fixatives can alter protein structure and epitope accessibility:
Isopropanol fixation (60%) is recommended for general antibody compatibility and has been successfully used in C. elegans immunostaining protocols
The fixation duration should be at least 10 minutes, but can be extended for longer periods
Fixation effects on antigenicity vary between antibodies, so optimization may be necessary
Fixed samples can be stored at -20°C in 60% isopropanol for at least a month without significant loss of antigenicity
It's important to note that the optimal fixation condition may need to be adjusted based on the specific characteristics of your C47E8.4 antibody and the cellular localization of the target protein.
Effective permeabilization is essential for allowing C47E8.4 antibody access to its target while maintaining tissue integrity. The polyacrylamide embedding method offers significant advantages:
Chemical permeabilization using 0.5% PBS-T (PBS with Triton X-100) provides initial cuticle disruption
Enzymatic permeabilization can be added for enhanced antibody penetration
The polyacrylamide gel immobilization prevents distortion or damage to the worm's body during permeabilization
This combined approach enables immunostaining across the whole body of well-preserved C. elegans
This method overcomes a major barrier in C. elegans immunostaining - permeabilizing the tough cuticle without compromising morphological integrity, which is particularly important for studying spatially-restricted expression patterns of proteins like C47E8.4.
When encountering weak or absent signals with C47E8.4 antibody, consider the following systematic troubleshooting approaches:
Antibody concentration: Adjust the primary antibody dilution; the optimal working concentration may need optimization from batch to batch
Permeabilization efficiency: Insufficient permeabilization of the C. elegans cuticle is a common issue; extend permeabilization time or try alternative permeabilization reagents
Epitope accessibility: The fixation method may mask the epitope; test alternative fixation protocols
Antibody quality: Verify antibody activity with positive controls; antibodies stored improperly may lose activity
Detection system: Ensure secondary antibody is compatible and functional; try signal amplification methods
Each step should be systematically tested and controlled to identify the limiting factor in the experimental setup.
Rigorous controls are critical for interpreting C47E8.4 antibody results:
Positive controls:
Samples with known expression of C47E8.4 protein
Recombinant C47E8.4 protein for Western blotting
Negative controls:
Omission of primary antibody to assess secondary antibody specificity
Pre-immune serum controls
C47E8.4 knockdown or knockout samples when available
Specificity controls:
Pre-absorption of antibody with purified antigen
Comparison with alternative antibodies against the same target
Multiple detection methods (e.g., ELISA confirmation of Western blot results)
These controls help validate that the observed signals truly represent C47E8.4 protein rather than experimental artifacts.
For co-immunoprecipitation (co-IP) and other advanced applications with C47E8.4 antibody:
Co-IP protocol:
Prepare C. elegans lysate under non-denaturing conditions
Pre-clear lysate with protein A/G beads
Incubate with C47E8.4 antibody (which is affinity-purified and suitable for immunoprecipitation)
Capture antibody-protein complexes with protein A/G beads
Wash stringently and elute
Analyze by Western blotting for interacting proteins
Additional advanced applications:
ChIP (Chromatin Immunoprecipitation): If C47E8.4 has DNA-binding properties
Proximity ligation assay: For detecting protein-protein interactions in situ
Super-resolution microscopy: For detailed subcellular localization studies
The polyclonal nature of the available C47E8.4 antibody makes it potentially suitable for recognizing multiple epitopes, which can be advantageous in precipitation techniques.
For rigorous quantification of C47E8.4 expression:
Western blot quantification:
Always include loading controls (e.g., actin, tubulin)
Use purified recombinant C47E8.4 protein to create a standard curve
Employ digital image analysis software for densitometry
Normalize signal to total protein using stain-free gels or similar approaches
Immunofluorescence quantification:
Maintain identical acquisition parameters across all samples
Include internal reference standards in each image
Use automated analysis algorithms to avoid bias
Report intensity values relative to control samples or reference structures
Statistical considerations:
Perform experiments with at least three biological replicates
Apply appropriate statistical tests based on data distribution
Report both effect size and statistical significance
Consider power analysis to determine adequate sample sizes
These approaches ensure that differences in C47E8.4 expression are accurately quantified and interpreted.
Interpreting subcellular localization of C47E8.4 requires:
Co-localization studies:
Use established markers for specific organelles or subcellular compartments
Calculate co-localization coefficients (e.g., Pearson's, Manders')
Employ super-resolution techniques for detailed localization studies
Tissue-specific considerations:
Be aware that localization may vary between tissues
Compare with known expression patterns from transcriptomic data
Consider tissue-specific binding partners that may affect localization
Validation approaches:
Confirm patterns with GFP-tagged C47E8.4 in transgenic animals
Use fractionation studies to biochemically verify subcellular distribution
Compare results from multiple fixation and permeabilization methods
Accurate interpretation requires considering both the biological context and technical limitations of immunostaining methods.
The commercially available C47E8.4 antibody has the following specifications:
| Parameter | Specification |
|---|---|
| Product Code | CSB-PA622096XA01CXY |
| Target Species | Caenorhabditis elegans |
| Host Species | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Immunogen | Recombinant C. elegans C47E8.4 protein |
| Purification Method | Antigen Affinity Purified |
| Form | Liquid |
| Storage Buffer | 0.03% Proclin 300, 50% Glycerol, 0.01M PBS (pH 7.4) |
| Validated Applications | ELISA, Western Blot |
| Production Time | Made-to-order (14-16 weeks) |
| Uniprot Accession | Q18691 |
| Usage | For Research Use Only |
This technical information is crucial for researchers to properly plan experiments and interpret results when working with this antibody .
The polyacrylamide embedding method offers several significant advantages for immunostaining C. elegans with antibodies like C47E8.4:
Immobilization benefits:
Maintains structural integrity of the worm during permeabilization
Prevents tissue distortion that commonly occurs with freeze-cracking methods
Allows for consistent and even permeabilization across the entire specimen
Improved antibody accessibility:
Facilitates penetration of antibodies through the tough cuticle
Enables whole-body immunostaining rather than restricted regions
Preserves cellular and subcellular structures for accurate localization studies
Protocol flexibility:
This method represents a significant advance over traditional techniques, enabling more reliable and comprehensive analysis of protein expression and localization in C. elegans.